JD Health stock stands 47.36 percent below its 52-week high
Published on 10/15/2026 at 20:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSValuation and market position
- On October 15, 2026, JD Health traded 47.36 percent below its HKD 71.70 52-week high.
- JD Health's price-to-earnings ratio stood at 16.67 on October 15, 2026.
- JD Health stock cost EUR 4.29 at Lang & Schwarz on October 15, 2026 at 7:52 p.m. CEST.
- Market capitalization stood at HKD 120.4 billion on October 15, 2026.
JD Health stock stood at HKD 37.74 on HKEX on October 15, 2026, 47.36 percent below its HKD 71.70 52-week high. The company also traded 18.53 percent above its HKD 31.84 52-week low. JD Health was trading at EUR 4.29 at Lang & Schwarz on October 15, 2026 at 7:52 p.m. CEST.
Range leaves room below the high
The Hong Kong quotation places the stock well below its yearly peak, while the current level remains above the annual low. Trading volume reached 16,254,199 shares, compared with an average of 8,107,062 shares, a 100.50 percent increase over the average. The figures describe the session's market position rather than a forecast.
Valuation and operating scale
JD Health had a price-to-earnings ratio of 16.67 and a market capitalization of HKD 120.4 billion on October 15, 2026. Yahoo Finance reported that the stock was down 34.10 percent from the start of 2026 in its October 15, 2026 analysis.
On August 13, 2026, GMT Eight reported first-half revenue of CNY 40.90 billion, up 15.90 percent year over year. Non-IFRS operating profit reached CNY 3.50 billion, up 40.30 percent, while the operating margin rose from 7.00 percent to 8.50 percent.
Comparison with peers
JD Health (HKEX, HKD): P/E 16.67, market capitalization HKD 120.4 billion
Alibaba (HKEX, HKD): minus 3.71 percent, P/E 24.45, market capitalization HKD 2.1 trillion
Tencent (HKEX, HKD): minus 1.32 percent, P/E 14.09, market capitalization HKD 3.8 trillion
What the calendar adds
The next investor focus is the company's next scheduled reporting date. The available company contact page directs shareholders to future corporate communications through the company website and HKEXnews.
Price remains the clearest market signal
JD Health's HKD 37.74 quotation sits closer to its annual low than its high, while the price-to-earnings ratio remains below Tencent's 14.09 only when viewed alongside the different business profiles and currencies of the comparison set.
The further course of trading is shown by the continuously updated real-time quote of JD Health stock.
JD Health stock facts
- Company: JD Health International Inc.
- ISIN: KYG5074A1004
- Ticker: 6618.HK
- Primary exchange: HKEX
- Price Lang & Schwarz as of October 15, 2026, 7:52 p.m. CEST: EUR 4.29
- Market capitalization: HKD 120.4 billion as of October 15, 2026
- 52-week range: HKD 31.84-71.70 as of October 15, 2026
- Sector / Industry: Healthcare / Medical - Pharmaceuticals
Market context: Current market reports.
